{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:23:35Z","timestamp":1784823815446,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82302975"],"award-info":[{"award-number":["No. 82302975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of North Sichuan Medical College","award":["No. CBY22-QDA19"],"award-info":[{"award-number":["No. CBY22-QDA19"]}]},{"name":"Joint Development Scientific Research Project of the Affiliated Hospital of North Sichuan Medical College and Guang\u2019an District People\u2019s Hospital","award":["No. 2025LHFZ03"],"award-info":[{"award-number":["No. 2025LHFZ03"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["No. 320.6750.2025-27-1"],"award-info":[{"award-number":["No. 320.6750.2025-27-1"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Provincial College Students\u2019 Innovation and Entrepreneurship Training Program","award":["No. S202510634042"],"award-info":[{"award-number":["No. S202510634042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04992-4","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:35:19Z","timestamp":1776530119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BANF1 as a potential prognostic biomarker associated with tumor-intrinsic programs and a complex immune landscape in lung adenocarcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Meihan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhike","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanze","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"3","key":"4992_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"4992_CR2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2014.3741","volume":"311","author":"MG Kris","year":"2014","unstructured":"Kris MG, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998\u20132006.","journal-title":"JAMA"},{"issue":"19","key":"4992_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2016;375(19):1823\u201333.","journal-title":"N Engl J Med"},{"key":"4992_CR4","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular profiling of lung adenocarcinoma. Nature, 2014. 511(7511): pp. 543\u201350.","DOI":"10.1038\/nature13385"},{"issue":"10027","key":"4992_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540\u201350.","journal-title":"Lancet"},{"issue":"22","key":"4992_CR6","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","volume":"378","author":"MD Hellmann","year":"2018","unstructured":"Hellmann MD, et al. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl J Med. 2018;378(22):2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"5","key":"4992_CR7","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam A, Prasad V. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. JAMA Netw Open. 2019;2(5):e192535.","journal-title":"JAMA Netw Open"},{"key":"4992_CR8","doi-asserted-by":"crossref","unstructured":"Sears RM, Roux KJ. Diverse cellular functions of barrier-to-autointegration factor and its roles in disease. J Cell Sci, 2020. 133(16).","DOI":"10.1242\/jcs.246546"},{"issue":"4","key":"4992_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1073\/pnas.95.4.1528","volume":"95","author":"MS Lee","year":"1998","unstructured":"Lee MS, Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc Natl Acad Sci U S A. 1998;95(4):1528\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4992_CR10","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1093\/nar\/gkab110","volume":"49","author":"JT Burgess","year":"2021","unstructured":"Burgess JT, et al. Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity. Nucleic Acids Res. 2021;49(6):3294\u2013307.","journal-title":"Nucleic Acids Res"},{"key":"4992_CR11","doi-asserted-by":"publisher","first-page":"1068347","DOI":"10.3389\/fcell.2022.1068347","volume":"10","author":"AK Balaji","year":"2022","unstructured":"Balaji AK, et al. Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers. Front Cell Dev Biol. 2022;10:1068347.","journal-title":"Front Cell Dev Biol"},{"key":"4992_CR12","doi-asserted-by":"crossref","unstructured":"Wang M et al. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade. J Immunother Cancer, 2023. 11(8).","DOI":"10.1136\/jitc-2023-007035"},{"issue":"4","key":"4992_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/hep.29606","volume":"67","author":"Q Shen","year":"2018","unstructured":"Shen Q, et al. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma. Hepatology. 2018;67(4):1360\u201377.","journal-title":"Hepatology"},{"issue":"5","key":"4992_CR14","first-page":"6488","volume":"16","author":"J Li","year":"2018","unstructured":"Li J, et al. Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer. Oncol Lett. 2018;16(5):6488\u201394.","journal-title":"Oncol Lett"},{"issue":"1","key":"4992_CR15","doi-asserted-by":"publisher","first-page":"188661","DOI":"10.1016\/j.bbcan.2021.188661","volume":"1877","author":"M Chen","year":"2022","unstructured":"Chen M, Linstra R, van Vugt M. Genomic instability, inflammatory signaling and response to cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2022;1877(1):188661.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4992_CR16","doi-asserted-by":"publisher","first-page":"1465348","DOI":"10.3389\/fimmu.2024.1465348","volume":"15","author":"Y He","year":"2024","unstructured":"He Y, et al. BANF1 is a novel prognostic biomarker linked to immune infiltration in head and neck squamous cell carcinoma. Front Immunol. 2024;15:1465348.","journal-title":"Front Immunol"},{"issue":"4","key":"4992_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12022-014-9345-4","volume":"25","author":"TJ Giordano","year":"2014","unstructured":"Giordano TJ. The cancer genome atlas research network: a sight to behold. Endocr Pathol. 2014;25(4):362\u20135.","journal-title":"Endocr Pathol"},{"key":"4992_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol. 2016;1418:93\u2013110.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"4992_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"7","key":"4992_CR20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"4992_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/jee\/39.2.269","volume":"39","author":"F Wilcoxon","year":"1946","unstructured":"Wilcoxon F. Individual comparisons of grouped data by ranking methods. J Econ Entomol. 1946;39:269.","journal-title":"J Econ Entomol"},{"issue":"4","key":"4992_CR22","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1097\/WNO.0000000000001627","volume":"43","author":"RJ Wubbels","year":"2023","unstructured":"Wubbels RJ. Kaplan-Meier Statistics to Estimate Treatment Success. J Neuroophthalmol. 2023;43(4):e360\u20131.","journal-title":"J Neuroophthalmol"},{"issue":"535","key":"4992_CR23","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1080\/01621459.2020.1713792","volume":"116","author":"RL Prentice","year":"2021","unstructured":"Prentice RL, Zhao S. Regression Models and Multivariate Life Tables. J Am Stat Assoc. 2021;116(535):1330\u201345.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"4992_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"},{"issue":"4","key":"4992_CR25","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4992_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","journal-title":"Epidemiology"},{"issue":"1","key":"4992_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama H, et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 2012;72(1):100\u201311.","journal-title":"Cancer Res"},{"key":"4992_CR28","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"5","key":"4992_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"4992_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40880-019-0427-z","volume":"39","author":"TX Huang","year":"2019","unstructured":"Huang TX, Fu L. The immune landscape of esophageal cancer. Cancer Commun (Lond). 2019;39(1):79.","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"4992_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4992_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34.","journal-title":"Genome Med"},{"issue":"43","key":"4992_CR33","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4992_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees MG, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12(2):109\u201316.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"4992_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijnurstu.2014.09.006","volume":"52","author":"TA Lang","year":"2015","unstructured":"Lang TA, Altman DG. Basic statistical reporting for articles published in biomedical journals: the Statistical Analyses and Methods in the Published Literature or the SAMPL Guidelines. Int J Nurs Stud. 2015;52(1):5\u20139.","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"4992_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00018-023-04721-y","volume":"80","author":"T Duan","year":"2023","unstructured":"Duan T, et al. Analysis of a rare progeria variant of Barrier-to-autointegration factor in Drosophila connects centromere function to tissue homeostasis. Cell Mol Life Sci. 2023;80(3):73.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4992_CR37","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.18632\/aging.205461","volume":"16","author":"Y Xu","year":"2024","unstructured":"Xu Y, et al. Identification of BANF1 as a novel prognostic biomarker in gastric cancer and validation via in-vitro and in-vivo experiments. Aging. 2024;16(2):1808\u201328.","journal-title":"Aging"},{"issue":"1","key":"4992_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"issue":"17","key":"4992_CR39","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1158\/1078-0432.CCR-13-2391","volume":"20","author":"MA Molina-Vila","year":"2014","unstructured":"Molina-Vila MA, et al. Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer. Clin Cancer Res. 2014;20(17):4647\u201359.","journal-title":"Clin Cancer Res"},{"key":"4992_CR40","doi-asserted-by":"publisher","first-page":"e140923221042","DOI":"10.2174\/1874467217666230914090621","volume":"17","author":"DV Lim","year":"2024","unstructured":"Lim DV, et al. Targeting Mutant-p53 for Cancer Treatment: Are We There Yet? Curr Mol Pharmacol. 2024;17:e140923221042.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"4992_CR41","doi-asserted-by":"publisher","first-page":"25492","DOI":"10.1038\/s41598-025-10346-x","volume":"15","author":"M Rose","year":"2025","unstructured":"Rose M, et al. The inner nuclear membrane protein, Banf1, has an essential role in triple negative breast cancer cell proliferation and survival. Sci Rep. 2025;15(1):25492.","journal-title":"Sci Rep"},{"issue":"7","key":"4992_CR42","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.7150\/ijbs.107279","volume":"21","author":"X Wang","year":"2025","unstructured":"Wang X, et al. VRK1\/BANF1\/GLI1 Axis Regulates Tumor Development and Progression of Colorectal Cancer. Int J Biol Sci. 2025;21(7):3144\u201363.","journal-title":"Int J Biol Sci"},{"key":"4992_CR43","doi-asserted-by":"crossref","unstructured":"Hoang PH, Landi MT. DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors. Cancers (Basel), 2022. 14(4).","DOI":"10.3390\/cancers14040961"},{"key":"4992_CR44","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.2147\/CMAR.S304869","volume":"13","author":"J He","year":"2021","unstructured":"He J, et al. Hypomethylation-Mediated AGR2 Overexpression Facilitates Cell Proliferation, Migration, and Invasion of Lung Adenocarcinoma. Cancer Manag Res. 2021;13:5177\u201385.","journal-title":"Cancer Manag Res"},{"key":"4992_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.semcancer.2020.12.018","volume":"83","author":"I Ansari","year":"2022","unstructured":"Ansari I, et al. CRISPR\/Cas mediated epigenome editing for cancer therapy. Semin Cancer Biol. 2022;83:570\u201383.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4992_CR46","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","volume":"14","author":"HJ Liu","year":"2023","unstructured":"Liu HJ, et al. mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion. Nat Commun. 2023;14(1):1214.","journal-title":"Nat Commun"},{"issue":"5","key":"4992_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ccell.2023.04.003","volume":"41","author":"A Obradovic","year":"2023","unstructured":"Obradovic A, et al. Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators. Cancer Cell. 2023;41(5):933\u2013e94911.","journal-title":"Cancer Cell"},{"issue":"1","key":"4992_CR48","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41467-019-11280-z","volume":"10","author":"M Leclerc","year":"2019","unstructured":"Leclerc M, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10(1):3345.","journal-title":"Nat Commun"},{"issue":"7948","key":"4992_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","volume":"614","author":"M Sorin","year":"2023","unstructured":"Sorin M, et al. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature. 2023;614(7948):548\u201354.","journal-title":"Nature"},{"issue":"1","key":"4992_CR50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41467-025-56546-x","volume":"16","author":"L Desharnais","year":"2025","unstructured":"Desharnais L, et al. Spatially mapping the tumour immune microenvironments of non-small cell lung cancer. Nat Commun. 2025;16(1):1345.","journal-title":"Nat Commun"},{"issue":"2","key":"4992_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.21147\/j.issn.1000-9604.2024.02.05","volume":"36","author":"S Chen","year":"2024","unstructured":"Chen S, et al. New roles of tumor-derived exosomes in tumor microenvironment. Chin J Cancer Res. 2024;36(2):151\u201366.","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"4992_CR52","first-page":"3453","volume":"16","author":"L Qin","year":"2024","unstructured":"Qin L, et al. Senescent Macrophages and the Lung Cancer Microenvironment: A New Perspective on Tumor Immune Evasion. Aging Dis. 2024;16(6):3453\u201365.","journal-title":"Aging Dis"},{"key":"4992_CR53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. Annu Rev Immunol. 2019;37:457\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"4992_CR54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, et al. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol. 2022;19(12):775\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4992_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.trecan.2023.03.006","volume":"9","author":"Y Chen","year":"2023","unstructured":"Chen Y, Liu Y, Han L. Spatial landscape of the tumor immune microenvironment. Trends Cancer. 2023;9(6):459\u201360.","journal-title":"Trends Cancer"},{"issue":"6280","key":"4992_CR56","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan N, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351(6280):1463\u20139.","journal-title":"Science"},{"issue":"6230","key":"4992_CR57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124\u20138.","journal-title":"Science"},{"key":"4992_CR58","doi-asserted-by":"publisher","first-page":"1611733","DOI":"10.3389\/pore.2024.1611733","volume":"30","author":"LJ T\u00f3th","year":"2024","unstructured":"T\u00f3th LJ, Mok\u00e1nszki A, M\u00e9hes G. The rapidly changing field of predictive biomarkers of non-small cell lung cancer. Pathol Oncol Res. 2024;30:1611733.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"4992_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon J, Bakhoum SF. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer. Cancer Discov. 2020;10(1):26\u201339.","journal-title":"Cancer Discov"},{"issue":"7668","key":"4992_CR60","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie KJ, et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature. 2017;548(7668):461\u20135.","journal-title":"Nature"},{"issue":"4","key":"4992_CR61","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","volume":"57","author":"S Dvorkin","year":"2024","unstructured":"Dvorkin S, et al. New frontiers in the cGAS-STING intracellular DNA-sensing pathway. Immunity. 2024;57(4):718\u201330.","journal-title":"Immunity"},{"issue":"7637","key":"4992_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321\u201330.","journal-title":"Nature"},{"issue":"2","key":"4992_CR63","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1002\/wsbm.70000","volume":"17","author":"F Moradi Kashkooli","year":"2025","unstructured":"Moradi Kashkooli F, et al. Mechanical Forces in Tumor Growth and Treatment: Perspectives From Biology, Physics, Engineering, and Mathematical Modeling. WIREs Mech Dis. 2025;17(2):e70000.","journal-title":"WIREs Mech Dis"},{"key":"4992_CR64","doi-asserted-by":"publisher","first-page":"1611713","DOI":"10.3389\/pore.2024.1611713","volume":"30","author":"A Lieber","year":"2024","unstructured":"Lieber A, et al. The role of immunotherapy in early-stage and metastatic NSCLC. Pathol Oncol Res. 2024;30:1611713.","journal-title":"Pathol Oncol Res"},{"issue":"10031","key":"4992_CR65","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet. 2016;387(10031):1909\u201320.","journal-title":"Lancet"},{"issue":"4","key":"4992_CR66","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ccell.2025.03.006","volume":"43","author":"SL Wang","year":"2025","unstructured":"Wang SL, Chan TA. Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy. Cancer Cell. 2025;43(4):641\u201364.","journal-title":"Cancer Cell"},{"issue":"7","key":"4992_CR67","first-page":"e88647","volume":"17","author":"M Puntambekar","year":"2025","unstructured":"Puntambekar M, et al. Predictive Biomarkers in Cancer Immunotherapy: A Narrative Review Across Selected Solid Tumors. Cureus. 2025;17(7):e88647.","journal-title":"Cureus"},{"issue":"1","key":"4992_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","volume":"22","author":"A da Costa","year":"2023","unstructured":"da Costa A, et al. Targeting replication stress in cancer therapy. Nat Rev Drug Discov. 2023;22(1):38\u201358.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4992_CR69","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1158\/2159-8290.CD-23-0641","volume":"14","author":"X Zhao","year":"2024","unstructured":"Zhao X, et al. Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress. Cancer Discov. 2024;14(3):508\u201323.","journal-title":"Cancer Discov"},{"key":"4992_CR70","doi-asserted-by":"publisher","first-page":"e18761429266116","DOI":"10.2174\/0118761429266116231123160809","volume":"17","author":"CL Yin","year":"2024","unstructured":"Yin CL, Ma YJ. The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance. Curr Mol Pharmacol. 2024;17:e18761429266116.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"4992_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15(1):49\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4992_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, et al. EMT: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04992-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04992-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04992-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:56:18Z","timestamp":1780026978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04992-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4992"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04992-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was reviewed and approved by the Institutional Review Board of the Affiliated Hospital of North Sichuan Medical College. All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent to participate in the study was obtained from all participants prior to sample collection and study-related procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"814"}}